Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly drops after cancer drug data seen as 'underwhelming'
Eli Lilly drops after cancer drug data seen as 'underwhelming'
Eli Lilly drops after cancer drug data seen as 'underwhelming'
Submitted by
admin
on January 23, 2013 - 10:43am
Source:
The Fly on the Wall
News Tags:
Eli Lilly
ramucirumab
gastric cancer
Headline:
Eli Lilly drops after cancer drug data seen as 'underwhelming'
Do Not Allow Advertisers to Use My Personal information
